Johnson & Johnson

Johnson & Johnson, founded in 1886 in New Brunswick, New Jersey, is one of the world's major pharmaceutical, medical device, and consumer packaged products manufacturers. In 2022, the company's total sales was 94.9 billion US dollars. As previously stated, the corporation is divided into three main business segments: medical devices and diagnostics, pharmaceuticals, and consumer packaged goods, with the latter accounting for 15 billion US dollars of the company's global revenue in 2022.

Since 2014, the company's pharmaceutical business has grown in importance. Pharmaceuticals currently account for around 55 percent of the company's total sales. Immunology and oncology are the most important therapeutic areas within Johnson & Johnson's pharmaceutical sector. Johnson & Johnson is also involved in infectious diseases and vaccinations. The business applied to the FDA (U.S. Food and Drug Administration) for emergency use permission for its COVID-19 vaccine in February 2021. There was a lot of enthusiasm surrounding this vaccine because it only requires one shot and does not need to be stored at extremely cold temperatures.

Johnson & Johnson remained the world's most valuable biotech and pharmaceutical company in terms of market value as of 2022. Johnson & Johnson is a diversified healthcare corporation that owns well-known brands such as Band-Aid, Neutrogena, Tylenol, and Acuvue contact lenses through its over 250 subsidiaries. Over the last two decades, the company's employment has steadily increased. It announced the biggest number of employees to date by the end of 2022, hitting about 153 thousand.

Founded: 1886

Headquarters: Johnson and Johnson Plaza, New Brunswick, New Jersey, U.S.

Website: https://www.jnj.com/